# Sekisui Chemical to acquire Veredus Laboratories

Sekisui Chemical, a Japanese diagnostics company, is acquiring Veredus Laboratories, a Singapore-based molecular diagnostics kit maker. The deal size was not disclosed, but market sources estimate Veredus could be worth around US$83 million.

- Type: Acquisition
- Announced: 2018-04-03
- Where: Singapore, Singapore
- Status: announced
- Products: molecular diagnostics kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sekisui Chemical](https://endata.com/companies/2709.md) (acquirer)
- [Veredus Laboratories](https://endata.com/companies/31073.md) (target)
- [Accuron MedTech](https://endata.com/companies/31074.md) (partner)

## Sources

- [straitstimes.com](https://www.straitstimes.com/business/companies-markets/temasek-backed-accuron-medtech-divests-veredus-labs-to-japans-sekisui), 2018-04-03: "Sekisui Chemical, a diagnostics company based in Japan, is acquiring home-grown Veredus Laboratories, a molecular diagnostics kit maker, in one of the largest exits in the local medtech space."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.